Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$390M |
| 2 |
Alibaba
BABA
|
+$330M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$253M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$325M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$303M |
| 3 |
PX
Praxair Inc
PX
|
+$213M |
| 4 |
COL
Rockwell Collins
COL
|
+$103M |
| 5 |
ANDV
Andeavor
ANDV
|
+$96.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.36% |
| 2 | Financials | 15.21% |
| 3 | Healthcare | 13.81% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIER
1326
DELISTED
TIER REIT, Inc.
TIER
| $3.22M | ﹤0.01% |
156,029
+1,946
| +1% | +$43.6K |
|
|
PRSP
1327
DELISTED
Perspecta Inc. Common Stock
PRSP
| $3.21M | ﹤0.01% |
186,486
-363,299
| -66% | -$8.05M |
|
1328
Vishay Intertechnology
VSH
$5.9B
| $3.21M | ﹤0.01% |
178,008
+2,700
| +2% | +$50.9K |
|
1329
The GEO Group
GEO
$4.19B
| $3.2M | ﹤0.01% |
162,620
+7,985
| +5% | +$181K |
|
1330
Sally Beauty Holdings
SBH
$1.56B
| $3.2M | ﹤0.01% |
187,719
+6,515
| +4% | +$122K |
|
1331
World Kinect Corp
WKC
$2B
| $3.2M | ﹤0.01% |
149,470
-17,682
| -11% | -$466K |
|
1332
Corcept Therapeutics
CORT
$11.9B
| $3.19M | ﹤0.01% |
241,044
-2,351
| -1% | -$31.1K |
|
1333
The Greenbrier Companies
GBX
$1.55B
| $3.19M | ﹤0.01% |
80,807
+2,655
| +3% | +$131K |
|
1334
La-Z-Boy
LZB
$1.67B
| $3.18M | ﹤0.01% |
115,071
+5,599
| +5% | +$158K |
|
1335
Cal-Maine
CALM
$3.96B
| $3.18M | ﹤0.01% |
75,312
+3,799
| +5% | +$176K |
|
1336
Genpact
G
$5.92B
| $3.17M | ﹤0.01% |
117,491
+6,370
| +6% | +$181K |
|
1337
S&T Bancorp
STBA
$1.86B
| $3.16M | ﹤0.01% |
83,640
+2,607
| +3% | +$105K |
|
1338
Healthcare Services Group
HCSG
$1.6B
| $3.16M | ﹤0.01% |
78,598
+4,398
| +6% | +$186K |
|
1339
New York Times
NYT
$12B
| $3.14M | ﹤0.01% |
141,063
+3,726
| +3% | +$94.4K |
|
|
SFLY
1340
DELISTED
Shutterfly, Inc.
SFLY
| $3.13M | ﹤0.01% |
77,965
-228
| -0.3% | -$12K |
|
|
USG
1341
DELISTED
Usg
USG
| $3.12M | ﹤0.01% |
73,141
+7,013
| +11% | +$300K |
|
|
MNR
1342
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $3.11M | ﹤0.01% |
251,132
+16,588
| +7% | +$241K |
|
1343
Bank OZK
OZK
$5.7B
| $3.11M | ﹤0.01% |
136,346
+7,742
| +6% | +$215K |
|
1344
Sensient Technologies
SXT
$5.43B
| $3.11M | ﹤0.01% |
55,731
+2,545
| +5% | +$166K |
|
|
NTRI
1345
DELISTED
NutriSystem, Inc.
NTRI
| $3.11M | ﹤0.01% |
70,894
+3,048
| +4% | +$115K |
|
1346
Matthews International
MATW
$878M
| $3.09M | ﹤0.01% |
76,286
+2,283
| +3% | +$97.2K |
|
1347
SPS Commerce
SPSC
$2.65B
| $3.09M | ﹤0.01% |
75,268
+598
| +0.8% | +$26.1K |
|
1348
Matsons
MATX
$6.44B
| $3.08M | ﹤0.01% |
95,852
+1,980
| +2% | +$73.3K |
|
1349
Paycom
PAYC
$7.94B
| $3.08M | ﹤0.01% |
25,130
+1,771
| +8% | +$227K |
|
1350
Regenxbio
RGNX
$655M
| $3.07M | ﹤0.01% |
73,422
+3,514
| +5% | +$206K |
|
Similar funds
Legal & General Group's Q4 2018 Portfolio in Review
As of Q4 2018, Legal & General Group held 3,449 positions worth $129B, down 7.6% from $140B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Legal & General Group deployed $9.23B of net new capital in Q4 2018, opening 63 new positions and adding to 2,242 existing holdings. Its largest new stake was Linde: 2,465,565 shares worth $381M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dell, an estimated $53.7M trimmed.
- Legal & General Group's largest Q4 2018 buy was Linde: 2,465,565 shares worth $381M.
- Legal & General Group added most to Alibaba in Q4 2018, an estimated $330M increase.
- Legal & General Group's biggest Q4 2018 reduction was Dell, cutting an estimated $53.7M.
- Legal & General Group fully exited Aetna Inc in Q4 2018, selling an estimated $325M.
- Legal & General Group's ten largest holdings make up 16% of its $129B portfolio in Q4 2018.
- Legal & General Group opened 63 new positions and closed 67 in Q4 2018.
- Legal & General Group's portfolio value fell 7.6% quarter-over-quarter to $129B.
Based on Legal & General Group's 13F filing for Q4 2018, filed 15 Feb 2019.